低出生体重是否与较低的阿迪波内克丁水平有关? - 一个系统的审查和元分析
Afnan Sabah Alhakeem1, Aleyna Hasturk1, Trine Witzner Hessel Lawaetz1
1Copenhagen University Hospital - Steno Diabetes Center Copenhagen, Herlev, Denmark.
PloS one
|December 2, 2025
概括
出生时体重低的个体具有较低的阿迪波内克丁水平,增加了患2型糖尿病的风险. 这一系统性审查证实了出生体重和脂肪素之间的联系,为疾病起源提供了洞察力.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 发展生物学 发展生物学
背景情况:
- 低出生体重与2型糖尿病的风险增加有关.
- 不成熟的脂肪组织发育和降低的阿迪波内克水平可能是这种风险的基础.
- 阿迪波涅丁是一种关键的胰岛素敏感性阿迪波金.
研究的目的:
- 系统地审查和分析检查循环阿迪波涅克丁水平与出生体重之间的关系的研究.
- 调查降低阿迪波涅丁对低出生体重个体2型糖尿病风险升高的潜在贡献.
主要方法:
- 67项研究的系统审查和元分析.
- 包括8000多个不同年龄组的个人.
- 聚合了皮尔森相关性分析,以评估出生体重和脂肪素之间的关系.
主要成果:
- 与正常出生体重的个体相比,低出生体重的个体表现出显著较低的阿迪波内克水平 (SMD = -0.46μg/ml).
- 在出生体重和阿迪波内克丁水平之间发现了中度的,统计学上显著的正相关性 (相关性估计 = 0.31).
- 观察到适度的异质性,但敏感性分析没有确定特定的驱动因素.
结论:
- 低出生体重个体的阿迪波内克水平降低可能会导致他们患2型糖尿病的风险增加.
- 研究结果表明,阿迪波内克丁在2型糖尿病的发育起源中可能发挥作用.
- 建立了出生体重和阿迪波内克丁之间显著的关联,为未来的研究和临床前景提供了信息.
相关概念视频
Drug Dosing: Obese Patients
202
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
202
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
225
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
225
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K


